Search
Search Funnelback University
- Refined by:
- Date: 2021
Your query has been expanded to `news stories` |u:www.enterprize.cam.ac.uk. Search for `news stories` |u:www.enterprise.cam.ac.uk instead.
41 -
50 of
63
search results for `news stories` |u:www.enterprise.cam.ac.uk or `news stories` |u:www.enterprize.cam.ac.uk
Fully-matching results
-
Student innovation and entrepreneurship training in China – Cambridge …
https://www.enterprise.cam.ac.uk/case-studies/student-innovation-and-entrepreneurship-training-in-china/
16 Jun 2021:
Cambridge Enterprise is supporting an innovation and entrepreneurship training programme for students at Shandong University. Read more
-
PolyProx Therapeutics receives £1m from LifeArc – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/cambridge-spin-out-polyprox-therapeutics-raises-an-additional-1m-seed-financing/
25 Feb 2021:
PolyProx Therapeutics, receives additional £1m from new investor, LifeArc to develop its novel biopharmaceuticals for the treatment of cancer.
-
Kubos Semiconductors: the search for more efficient LEDs – Cambridge…
https://www.enterprise.cam.ac.uk/case-studies/one-thing-leads-another-search-efficient-leds/
30 Apr 2021:
Kubos Semiconductors was set up to commercialise a technology for greener LEDs that was developed as a result of a consultancy project.
-
Ajay Chowdury named Chair of Board – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/ajay-chowdhury-named-chair-of-cambridge-enterprise-board/
25 Feb 2021:
Ajay Chowdhury assumed leadership of the Board in January, overseeing the strategy of Cambridge Enterprise, which supports knowledge transfer.
-
Quethera: a new vision for saving glaucoma patients’ eyesight –…
https://www.enterprise.cam.ac.uk/case-studies/a-new-vision-for-saving-glaucoma-patients-eyesight-2/
30 Apr 2021:
With such a high unmet medical need, this is good news for patients who are at risk of losing their sight.
-
Apollo Therapeutics launches as multinational company, backed by…
https://www.enterprise.cam.ac.uk/news/apollo-therapeutics-launches-as-multinational-company-backed-by-100m-investment/
17 Aug 2021:
A pioneering collaboration—devised by Cambridge, Imperial, UCL and embraced by AstraZeneca, GlaxoSmithKline, Johnson & Johnson Innovation—to speed translation of breakthrough science into therapeutics launches today as a £100 million company.
-
Q-Flo: progress towards a materials revolution – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/making-progress-towards-a-materials-revolution-2/
5 May 2021:
A consultancy contract led to some surprising results and a major project that could prove world-changing.
-
Cambridge and Shandong University sign agreement to support…
https://www.enterprise.cam.ac.uk/news/cambridge-and-shandong-university-sign-agreement-to-support-innovation-and-entrepreneurship/
3 Mar 2021:
Cambridge and Shandong University sign agreement to support innovation and entrepreneurship
-
Novel therapeutic for neuropathic pain – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/new-approach-could-revolutionise-treatment-of-neuropathic-pain/
2 Aug 2021:
A new approach to indirectly modulating the effect of the TRPV1, an important initiator of the sensation of pain.
-
Leading Cambridge entrepreneur takes up residence at Cambridge…
https://www.enterprise.cam.ac.uk/news/leading-cambridge-entrepreneur-takes-residence-cambridge-enterprise/
22 Oct 2021:
Mobile menu. Mobile menu. Search. back. back. back. back. back. 28 January 2019. Leading Cambridge entrepreneur takes up residence at Cambridge Enterprise. Share:. Paul Bailey, one of Cambridge’s most influential entrepreneurs and Executive
16 Jun 2021:
Cambridge Enterprise is supporting an innovation and entrepreneurship training programme for students at Shandong University. Read more
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.